Value of allogeneic versus autologous stem cell transplantation and chemotherapy in patients with myelodysplastic syndromes and secondary acute myeloid leukemia. Final results of a prospective randomized European Intergroup Trial
DE WITTE, Theo, HAGEMEIJER, Anne, AMADORI, Sergio, MUUS, Petra, JANSEN, Joop H, HELLSTRÖM-LINDBERG, Eva, KOVACSOVICS, Tibor, WIJERMANS, Pierre, OSSENKOPPELE, Gert, GRATWOHL, Alois, MARIE, Jean-Pierre, WILLEMZE, Roel, SUCIU, Stefan, BELHABRI, Amin, DELFORGE, Michel, KOBBE, Guido, SELLESLAG, Dominik, SCHOUTEN, Harry C, FERRANT, Augustin, BIERSACK, Harald
Published in Haematologica (Roma) (01.10.2010)
Published in Haematologica (Roma) (01.10.2010)
Get full text
Journal Article
Specific scoring systems to predict survival of patients with high-risk myelodysplastic syndrome (MDS) and de novo acute myeloid leukemia (AML) after intensive antileukemic treatment based on results of the EORTC-GIMEMA AML-10 and intergroup CRIANT studies
Oosterveld, Margriet, Suciu, Stefan, Muus, Petra, Germing, Ulrich, Delforge, Michel, Belhabri, Amin, Aul, Carlo, Selleslag, Dominik, Ferrant, Augustin, Marie, Jean-Pierre, Amadori, Sergio, Jehn, Ulrich, Mandelli, Franco, Hess, Uwe, Hellström-Lindberg, Eva, Cakmak-Wollgast, Songuel, Vignetti, Marco, Labar, Boris, Willemze, Roel, de Witte, Theo
Published in Annals of hematology (01.01.2015)
Published in Annals of hematology (01.01.2015)
Get full text
Journal Article